SIGA Technologies/$SIGA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About SIGA Technologies
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.
Ticker
$SIGA
Sector
Primary listing
Industry
Pharmaceuticals
Headquarters
Employees
46
ISIN
US8269171067
Website
SIGA Metrics
BasicAdvanced
$490M
10.22
$0.67
0.93
$0.60
8.75%
Price and volume
Market cap
$490M
Beta
0.93
52-week high
$12.83
52-week low
$4.95
Average daily volume
400K
Dividend rate
$0.60
Financial strength
Current ratio
8.404
Quick ratio
6.095
Long term debt to equity
0.304
Total debt to equity
0.563
Profitability
EBITDA (TTM)
56.988
Gross margin (TTM)
65.98%
Net profit margin (TTM)
40.33%
Operating margin (TTM)
46.91%
Effective tax rate (TTM)
22.08%
Revenue per employee (TTM)
$2,620,000
Management effectiveness
Return on assets (TTM)
14.39%
Return on equity (TTM)
25.47%
Valuation
Price to earnings (TTM)
10.223
Price to revenue (TTM)
4.067
Price to book
2.27
Price to tangible book (TTM)
2.28
Price to free cash flow (TTM)
7.909
Free cash flow yield (TTM)
12.64%
Free cash flow per share (TTM)
86.74%
Dividend yield (TTM)
8.75%
Growth
Revenue change (TTM)
-23.37%
Earnings per share change (TTM)
-39.12%
3-year revenue growth (CAGR)
-4.78%
10-year revenue growth (CAGR)
41.34%
3-year earnings per share growth (CAGR)
-10.37%
10-year earnings per share growth (CAGR)
-18.25%
What the Analysts think about SIGA
Analyst ratings (Buy, Hold, Sell) for SIGA Technologies stock.
Bulls say / Bears say
SIGA Technologies secured a $138 million contract from the U.S. Department of Health and Human Services for its TPOXX treatments, indicating strong government support and potential revenue growth. (InvestorPlace)
The company reported a net income of $45.76 million in Q4 2024, showcasing robust financial performance and profitability. (Google Finance)
SIGA's collaboration with Calidi Biotherapeutics to advance RTNova virotherapy for cancer treatment diversifies its product pipeline and opens new market opportunities. (StockTitan)
The failure of TPOXX to meet primary endpoints in the STOMP clinical trial for Mpox treatment raises concerns about the drug's efficacy and future sales. (StockTitan)
The abrupt termination of Chief Medical Officer Dr. Jay Varma, coupled with leaked videos suggesting potential misinformation, may damage the company's reputation and investor trust. (GlobeNewswire)
A 9.69% decline in SIGA's stock over a recent month, underperforming the medical sector, indicates potential investor concerns about the company's prospects. (Nasdaq)
Data summarised monthly by Lightyear AI. Last updated on 11 Jul 2025.
SIGA Financial Performance
Revenues and expenses
SIGA Earnings Performance
Company profitability
SIGA News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for SIGA Technologies stock?
SIGA Technologies (SIGA) has a market cap of $490M as of July 15, 2025.
What is the P/E ratio for SIGA Technologies stock?
The price to earnings (P/E) ratio for SIGA Technologies (SIGA) stock is 10.22 as of July 15, 2025.
Does SIGA Technologies stock pay dividends?
Yes, the SIGA Technologies (SIGA) stock pays dividends to shareholders. As of July 15, 2025, the dividend rate is $0.6 and the yield is 8.75%. SIGA Technologies has a payout ratio of 0% on a trailing twelve-month basis.
When is the next SIGA Technologies dividend payment date?
The next SIGA Technologies (SIGA) dividend payment date is unconfirmed.
What is the beta indicator for SIGA Technologies?
SIGA Technologies (SIGA) has a beta rating of 0.93. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.